Diagnostic Criteria for Hepatorenal Syndrome
The diagnostic criteria for hepatorenal syndrome (HRS) require serum creatinine >1.5 mg/dL (133 µmol/L) in a patient with cirrhosis and ascites, with no improvement after at least 2 days of diuretic withdrawal and volume expansion with albumin (1 g/kg/day up to 100 g/day maximum), while excluding shock, nephrotoxic drugs, and parenchymal kidney disease. 1, 2
Core Diagnostic Requirements
The diagnosis of HRS is fundamentally one of exclusion—you must systematically rule out other causes of acute kidney injury before making this diagnosis 2. The most recent and authoritative criteria come from the 2015 International Club of Ascites consensus 1, which updated the traditional 2007 criteria 3.
Mandatory Criteria (All Must Be Present):
Cirrhosis with ascites - HRS does not occur without ascites 3
Serum creatinine >1.5 mg/dL (133 µmol/L) 2
- Note: The 2015 criteria eliminated fixed creatinine thresholds for defining AKI stages, but this 1.5 mg/dL threshold remains for HRS diagnosis 1
No improvement after volume challenge 3, 2
- Must withdraw diuretics (if patient is taking them)
- Administer albumin at 1 g/kg body weight/day up to maximum 100 g/day for at least 2 days
- Creatinine must fail to decrease to ≤1.5 mg/dL after this challenge
No current or recent nephrotoxic drugs 3, 2
- Including NSAIDs, aminoglycosides, contrast agents
HRS Subtypes
Once HRS is diagnosed, classify it into two types based on progression 3, 2:
Type 1 HRS (now termed HRS-AKI):
- Rapidly progressive renal failure
- Doubling of initial serum creatinine to ≥2.5 mg/dL OR
- 50% reduction in 24-hour creatinine clearance to <20 mL/minute
- Occurs in <2 weeks
- Median survival approximately 1 month without treatment 2
Type 2 HRS:
- Stable or slowly progressive renal dysfunction
- Does not meet Type 1 criteria for rapid progression
- Often associated with refractory ascites 3
Critical Diagnostic Pitfalls
The albumin challenge is non-negotiable - many clinicians skip this step, but you cannot diagnose HRS without documenting failure to respond to adequate volume expansion 3, 2. Older studies often failed to measure cardiac filling pressures, potentially missing occult hypovolemia 3.
Serum creatinine overestimates GFR in cirrhosis due to decreased muscle mass, increased tubular secretion, volume of distribution changes, and bilirubin interference with assays 1. This means a "normal" creatinine may mask significant renal dysfunction.
Parenchymal kidney disease can coexist - the 2015 criteria acknowledge that HRS physiology can occur alongside tubular injury or chronic kidney disease 1. The key is whether the predominant mechanism is functional (HRS) versus structural.
Practical Diagnostic Algorithm
- Confirm cirrhosis with ascites - no ascites = not HRS
- Document creatinine >1.5 mg/dL
- Stop diuretics immediately
- Give albumin challenge: 1 g/kg/day (max 100 g/day) × 2 days minimum
- Recheck creatinine - if still >1.5 mg/dL, proceed
- Exclude shock - check blood pressure, perfusion
- Review medication list - eliminate nephrotoxins
- Check urine studies:
- Protein <500 mg/day
- Microscopy for RBCs (<50/hpf)
- Obtain renal ultrasound - rule out obstruction, structural disease
- If all criteria met → Diagnose HRS and classify type based on progression
Contemporary Updates
The 2021 AASLD guidance 4 emphasizes that diagnostic paracentesis should include specific tests based on clinical context, and the newer criteria recognize that strict cutoffs may miss patients who would benefit from HRS-specific therapy. Recent research 5, 6, 7 highlights that biomarkers like neutrophil gelatinase-associated lipocalin (NGAL) and fractional excretion of sodium may help differentiate HRS from acute tubular necrosis, though these are not yet incorporated into formal diagnostic criteria.
The 2015 criteria identify more HRS cases than the 2007 criteria (12.7% vs 7.5% in one study), which is clinically important because these patients require specific vasoconstrictor therapy 8. The elimination of fixed creatinine thresholds for AKI staging allows earlier recognition while maintaining the 1.5 mg/dL threshold for HRS diagnosis 1.